{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05108974",
            "orgStudyIdInfo": {
                "id": "UMN-1506M74642"
            },
            "secondaryIdInfos": [
                {
                    "id": "R01AA024123",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01AA024123"
                }
            ],
            "organization": {
                "fullName": "University of Minnesota",
                "class": "OTHER"
            },
            "briefTitle": "Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study",
            "officialTitle": "Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study",
            "acronym": "CHOLINE4",
            "therapeuticArea": [
                "Other"
            ],
            "study": "choline-supplementation-as-a-neurodevelopmental-intervention-in-fetal-alcohol-spectrum-disorders-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-10-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-08-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-08-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-10-26",
            "studyFirstSubmitQcDate": "2021-10-26",
            "studyFirstPostDateStruct": {
                "date": "2021-11-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-22",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Jeff Wozniak",
                "investigatorTitle": "Professor",
                "investigatorAffiliation": "University of Minnesota"
            },
            "leadSponsor": {
                "name": "Jeff Wozniak",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a randomized, double-blind controlled trial of choline supplementation in children with Fetal Alcohol Spectrum Disorders (FASD). The study is comparing two administration durations (3 months vs. 6 months) of choline. The primary outcome measures are cognitive measures.",
            "detailedDescription": "This project is the fourth in a series of randomized, double-blind controlled trials of choline bitartrate in children ages 2-5 (under 6) years with prenatal alcohol exposure. Pre-clinical data suggests that choline may attenuate the cognitive deficits caused by prenatal alcohol exposure (especially memory deficits). This study will evaluate the effects of daily choline supplementation in two dosing regimens (3 months choline vs. 6 months choline). Outcome measures include an elicited imitation memory paradigm, IQ measures, and measures of memory and executive functioning, and behavior."
        },
        "conditionsModule": {
            "conditions": [
                "Fetal Alcohol Spectrum Disorders"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "3 months choline bitartrate",
                    "type": "EXPERIMENTAL",
                    "description": "Over the 9-month study, participants will receive a total of 3 months of choline bitartrate (19 mg/kg) and a total of 6 months of placebo",
                    "interventionNames": [
                        "Drug: Choline Bitartrate"
                    ]
                },
                {
                    "label": "6 months choline bitartrate",
                    "type": "EXPERIMENTAL",
                    "description": "Over the 9-month study, participants will receive a total of 6 months of choline bitartrate (19 mg/kg) and a total of 3 months of placebo",
                    "interventionNames": [
                        "Drug: Choline Bitartrate"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Choline Bitartrate",
                    "description": "Powdered drink mix for daily consumption",
                    "armGroupLabels": [
                        "3 months choline bitartrate",
                        "6 months choline bitartrate"
                    ],
                    "otherNames": [
                        "choline bitartrate formulated in drink mix specifically for this study"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Elicited Imitation Memory Task (EI) (P.J. Bauer et al 1992 laboratory paradigm)",
                    "description": "Elicited Imitation short-delay memory measure (percent correct for recall)",
                    "timeFrame": "Change from baseline to 9 months"
                },
                {
                    "measure": "Stanford-Binet Intelligence Test (SB-5)",
                    "description": "Stanford Binet Intelligence Test - 5th Edition",
                    "timeFrame": "Change from baseline to 9 months"
                },
                {
                    "measure": "Minnesota Executive Function Scale (MEFS)",
                    "description": "Minnesota Executive Function Scale - Early Childhood Version",
                    "timeFrame": "Change from baseline to 9 months"
                },
                {
                    "measure": "NIH Toolbox Flanker Test",
                    "description": "NIH Toolbox Flanker Inhibitory and Control Test",
                    "timeFrame": "Change from baseline to 9 months"
                },
                {
                    "measure": "NIH Toolbox Picture Sequence Memory Test",
                    "description": "NIH Toolbox Picture Sequence Memory Test",
                    "timeFrame": "Change from baseline to 9 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Child Behavior Checklist (CBCL)",
                    "description": "Child Behavior Checklist - Parent Report Version",
                    "timeFrame": "Change from baseline to 9 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Ages 2.5 years to 5 years old (\\<6 years of age) at enrollment\n* Prenatal alcohol exposure\n* Available parent or legal guardian capable of giving informed consent for participation.\n\nExclusion Criteria:\n\n* History of a neurological condition (ex. epilepsy, traumatic brain injury)\n* History of a medical condition known to affect brain function\n* Other neurodevelopmental disorder (ex. autism, Down syndrome)\n* History of very low birthweight (\\<1500 grams)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "30 Months",
            "maximumAge": "72 Months",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jeffrey R Wozniak, Ph.D.",
                    "role": "CONTACT",
                    "phone": "612-598-0041",
                    "email": "jwozniak@umn.edu"
                },
                {
                    "name": "Michael K Georgieff, M.D.",
                    "role": "CONTACT",
                    "phone": "712-626-2971",
                    "email": "georg001@umn.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jeffrey R Wozniak, Ph.D.",
                    "affiliation": "University of Minnesota",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Minnesota",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55454",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jeffrey R Wozniak, Ph.D.",
                            "role": "CONTACT",
                            "phone": "612-273-9741",
                            "email": "jwozniak@umn.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000063647",
                    "term": "Fetal Alcohol Spectrum Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005315",
                    "term": "Fetal Diseases"
                },
                {
                    "id": "D000011248",
                    "term": "Pregnancy Complications"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000020751",
                    "term": "Alcohol-Induced Disorders"
                },
                {
                    "id": "D000019973",
                    "term": "Alcohol-Related Disorders"
                },
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M30146",
                    "name": "Fetal Alcohol Spectrum Disorders",
                    "asFound": "Fetal Alcohol Spectrum Disorders",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8445",
                    "name": "Fetal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M22508",
                    "name": "Alcohol-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21842",
                    "name": "Alcohol-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002794",
                    "term": "Choline"
                }
            ],
            "ancestors": [
                {
                    "id": "D000008082",
                    "term": "Lipotropic Agents"
                },
                {
                    "id": "D000000960",
                    "term": "Hypolipidemic Agents"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000057847",
                    "term": "Lipid Regulating Agents"
                },
                {
                    "id": "D000018697",
                    "term": "Nootropic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6034",
                    "name": "Choline",
                    "asFound": "400,000",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3777",
                    "name": "Ethanol",
                    "relevance": "LOW"
                },
                {
                    "id": "M4278",
                    "name": "Hypolipidemic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M28883",
                    "name": "Lipid Regulating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20774",
                    "name": "Nootropic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "T443",
                    "name": "Choline",
                    "asFound": "Shown",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "NootAg",
                    "name": "Nootropic Agents"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "Lipd",
                    "name": "Lipid Regulating Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}